About this episode
Discover the science behind cagrilitide, a next-generation peptide being studied for its potential role in weight management, metabolic health, and beyond. In this episode, we explore how cagrilitide works as an amylin and calcitonin receptor agonist, its connection to appetite regulation, blood sugar balance, and why researchers are so interested in its combination with GLP-1 therapies. Learn about the latest findings, possible benefits, and what the future may hold for this promising peptide.
Get every episode summarized
Each time The Peptide Effect publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Peptide Effect
The Hidden GLP-1 Switch: How These Drugs May Reprogram Pancreatic Cells
The Peptide Effect
The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?
The Peptide Effect
Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and...
The Peptide Effect
Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and...
The Peptide Effect